Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
FFIN
|
Ronald David Butler Ii
CAO |
BUY
Grant, award, or other acquisition
|
Direct | 2,120 Added 1.9% |
-
|
Oct 22
2019 |
FFIN
|
J Bruce Hildebrand
Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 829 Reduced 0.75% |
$29,330
$35.38 p/Share
|
Oct 22
2019 |
FFIN
|
J Bruce Hildebrand
Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct | 2,120 Added 1.88% |
-
|
Oct 22
2019 |
FFIN
|
T. Luke Longhofer
Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 390 Reduced 3.29% |
$13,798
$35.38 p/Share
|
Oct 22
2019 |
FFIN
|
T. Luke Longhofer
Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct | 1,413 Added 10.65% |
-
|
Oct 22
2019 |
FFIN
|
J. Kyle Mc Vey
EVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 469 Reduced 6.09% |
$16,593
$35.38 p/Share
|
Oct 22
2019 |
FFIN
|
J. Kyle Mc Vey
EVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct | 1,272 Added 14.18% |
-
|
Oct 22
2019 |
FFIN
|
Randall Allen Roewe
Chief Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 397 Reduced 3.54% |
$14,045
$35.38 p/Share
|
Oct 22
2019 |
FFIN
|
Randall Allen Roewe
Chief Risk Officer |
BUY
Grant, award, or other acquisition
|
Direct | 2,120 Added 15.89% |
-
|
Oct 22
2019 |
FFIN
|
F Scott Dueser
Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Indirect | 1,658 Reduced 0.0% |
$58,660
$35.38 p/Share
|
Oct 22
2019 |
FFIN
|
F Scott Dueser
Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Indirect | 4,240 Added 0.0% |
-
|
Oct 22
2019 |
CHX
|
Sivasankaran Somasundaram
President & CEO |
BUY
Bona fide gift
|
Indirect | 40,598 Added 43.12% |
-
|
Oct 22
2019 |
CHX
|
Sivasankaran Somasundaram
President & CEO |
SELL
Bona fide gift
|
Direct | 40,598 Reduced 8.6% |
-
|
Oct 22
2019 |
SILO
|
Eric Weisblum
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 200 Added 0.34% |
$90
$0.45 p/Share
|
Oct 22
2019 |
CNS
|
Robert Hamilton Steers
Executive Chairman |
SELL
Bona fide gift
|
Indirect | 85,000 Reduced 1.25% |
-
|
Oct 22
2019 |
ZYXI
|
Giuseppe Papandrea
COO - Zynex Medical, Inc. |
BUY
Grant, award, or other acquisition
|
Direct | 5,000 Added 12.5% |
-
|
Oct 22
2019 |
BASWQ
|
Silver Point Capital L.P.
Director |
SELL
Open market or private sale
|
Direct | 100,000 Reduced 4.41% |
$79,000
$0.79 p/Share
|
Oct 22
2019 |
RRTS
|
Elliott International, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 866 Added 0.0% |
$9,794
$11.31 p/Share
|
Oct 22
2019 |
ATEX
|
Owl Creek Asset Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 300 Added 0.01% |
$11,697
$38.99 p/Share
|
Oct 22
2019 |
RIV
|
Rivernorth Capital Management, LLC |
SELL
Open market or private sale
|
Direct | 51,429 Reduced 83.33% |
$2,057
$0.04 p/Share
|
Oct 22
2019 |
STKL
|
Ardsley Advisory Partners LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 5,000 Added 0.04% |
$7,650
$1.53 p/Share
|
Oct 22
2019 |
STR
|
Hite Hedge Asset Management LLC |
SELL
Open market or private sale
|
Direct | 117,627 Reduced 5.84% |
$766,928
$6.52 p/Share
|
Oct 22
2019 |
CARG
|
Parafestas Anastasios
Director |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 0.24% |
$315,600
$31.56 p/Share
|
Oct 22
2019 |
NGM
|
Column Group L P
Director |
BUY
Open market or private purchase
|
Direct | 2,300 Added 0.94% |
$27,600
$12.0 p/Share
|
Oct 22
2019 |
ONB
|
Jeffrey L Knight
CHIEF GOVERNMENT RELATIONS OFF |
SELL
Bona fide gift
|
Direct | 450 Reduced 0.48% |
-
|
Oct 22
2019 |
ZM
|
Aparna Bawa
Chief Operating Officer |
SELL
Open market or private sale
|
Indirect | 20,000 Reduced 5.56% |
$1,273,600
$63.68 p/Share
|
Oct 22
2019 |
COST
|
Patrick J Callans
Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 6,749 Reduced 10.15% |
$2,024,498
$299.97 p/Share
|
Oct 22
2019 |
COST
|
Susan L Decker
Director |
BUY
Grant, award, or other acquisition
|
Direct | 901 Added 2.2% |
-
|
Oct 22
2019 |
COST
|
Kenneth D Denman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 901 Added 15.99% |
-
|
Oct 22
2019 |
COST
|
Richard A Galanti
Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 6,911 Reduced 19.71% |
$2,073,093
$299.97 p/Share
|
Oct 22
2019 |
COST
|
Daniel M. Hines |
BUY
Grant, award, or other acquisition
|
Direct | 5,470 Added 17.19% |
-
|
Oct 22
2019 |
COST
|
Daniel M. Hines |
SELL
Payment of exercise price or tax liability
|
Direct | 2,301 Reduced 8.24% |
$690,231
$299.97 p/Share
|
Oct 22
2019 |
COST
|
Hamilton E James
Director |
BUY
Grant, award, or other acquisition
|
Direct | 901 Added 2.21% |
-
|
Oct 22
2019 |
COST
|
W Craig Jelinek
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 13,705 Reduced 4.12% |
$4,111,089
$299.97 p/Share
|
Oct 22
2019 |
COST
|
James C Klauer
Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 2,857 Reduced 5.08% |
$857,014
$299.97 p/Share
|
Oct 22
2019 |
COST
|
Richard M Libenson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 901 Added 18.57% |
-
|
Oct 22
2019 |
COST
|
John W Meisenbach
Director |
BUY
Grant, award, or other acquisition
|
Direct | 901 Added 6.16% |
-
|
Oct 22
2019 |
COST
|
Paul G Moulton
Executive VP |
SELL
Payment of exercise price or tax liability
|
Direct | 2,467 Reduced 6.85% |
$740,026
$299.97 p/Share
|
Oct 22
2019 |
COST
|
James P. Murphy
Executive VP |
SELL
Payment of exercise price or tax liability
|
Direct | 2,467 Reduced 5.41% |
$740,026
$299.97 p/Share
|
Oct 22
2019 |
COST
|
Joseph P Portera
Executive VP |
SELL
Payment of exercise price or tax liability
|
Direct | 7,920 Reduced 33.32% |
$2,375,762
$299.97 p/Share
|
Oct 22
2019 |
COST
|
Jeffrey S Raikes
Director |
BUY
Grant, award, or other acquisition
|
Direct | 901 Added 2.58% |
-
|
Oct 22
2019 |
COST
|
John W Stanton
Director |
BUY
Grant, award, or other acquisition
|
Direct | 901 Added 4.09% |
-
|
Oct 22
2019 |
COST
|
Mary Agnes Wilderotter
Director |
BUY
Grant, award, or other acquisition
|
Direct | 901 Added 9.89% |
-
|
Oct 22
2019 |
COST
|
Charles T Munger
Director |
BUY
Grant, award, or other acquisition
|
Direct | 901 Added 0.54% |
-
|
Oct 22
2019 |
PEN
|
James Robert Pray
President, International |
SELL
Open market or private sale
|
Indirect | 5,333 Reduced 1.12% |
$800,270
$150.06 p/Share
|
Oct 22
2019 |
ACN
|
Omar Abbosh
Grp Chief Exec-Com, Med & Tech |
SELL
Payment of exercise price or tax liability
|
Direct | 8,073 Reduced 13.83% |
$1,495,281
$185.22 p/Share
|
Oct 22
2019 |
ACN
|
Omar Abbosh
Grp Chief Exec-Com, Med & Tech |
BUY
Grant, award, or other acquisition
|
Direct | 17,171 Added 22.73% |
-
|
Oct 22
2019 |
ACN
|
Gianfranco Casati
CEO-Growth Markets |
BUY
Grant, award, or other acquisition
|
Direct | 24,612 Added 30.67% |
-
|
Oct 22
2019 |
ACN
|
Richard P Clark
Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,452 Reduced 7.75% |
$268,939
$185.22 p/Share
|
Oct 22
2019 |
ACN
|
Richard P Clark
Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct | 4,204 Added 18.32% |
-
|
Oct 22
2019 |